HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olga Grzybowska-Izydorczyk Selected Research

Phosphotransferases (Kinase)

3/2012mTOR kinase inhibitors as a treatment strategy in hematological malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olga Grzybowska-Izydorczyk Research Topics

Disease

6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2016 - 12/2006
5Hematologic Neoplasms (Hematological Malignancy)
07/2021 - 02/2008
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2024 - 08/2017
4Neoplasms (Cancer)
01/2023 - 02/2008
3Leukemia
01/2023 - 07/2017
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 02/2008
2Lymphoma (Lymphomas)
07/2021 - 09/2013
2Multiple Myeloma
07/2021 - 09/2013
1Leukocytosis (Pleocytosis)
01/2023
1Fibrosis (Cirrhosis)
01/2023
1Primary Myelofibrosis (Myelosclerosis)
01/2023
1Hemorrhage
08/2017
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2013
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2013
1Disease Progression
03/2013
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2008
1Hypersensitivity (Allergy)
08/2007

Drug/Important Bio-Agent (IBA)

3Imatinib Mesylate (Gleevec)FDA Link
04/2024 - 07/2017
3Inhibitor of Apoptosis ProteinsIBA
01/2021 - 02/2008
3CladribineFDA LinkGeneric
01/2020 - 08/2007
2Tyrosine Kinase InhibitorsIBA
04/2024 - 01/2022
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2015
2SurvivinIBA
01/2015 - 02/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 12/2012
2Interleukin-10 (Interleukin 10)IBA
03/2013 - 12/2012
1Syntex adjuvant formulationIBA
01/2023
1Reticulin (Reticular Fiber)IBA
01/2023
1ruxolitinibIBA
01/2023
1ponatinibIBA
01/2022
1NF-kappa B (NF-kB)IBA
01/2021
1CaspasesIBA
01/2021
1Carrier Proteins (Binding Protein)IBA
01/2021
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2020
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2020
1InterferonsIBA
08/2017
1Messenger RNA (mRNA)IBA
12/2016
1CytokinesIBA
08/2015
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2015
1Cytotoxins (Cytolysins)IBA
03/2012
1Phosphotransferases (Kinase)IBA
03/2012
1Antineoplastic Agents (Antineoplastics)IBA
03/2012
1aspartyllysineIBA
12/2009
1Rituximab (Mabthera)FDA Link
08/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2007
1Bortezomib (Velcade)FDA Link
12/2006
1Monoclonal AntibodiesIBA
12/2006

Therapy/Procedure

2Hematopoietic Stem Cell Transplantation
07/2021 - 09/2013
1Therapeutics
01/2022
1Cesarean Section (Caesarean Section)
08/2017
1Drug Therapy (Chemotherapy)
09/2013